Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04686552 · ClinicalTrials.gov registry record · NA

Effect Cinnamon Spice on Postprandial Glucose and Insulin Responses

A NA study of Overweight and Obesity and Normal Weight, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT04686552 is a NA study of Overweight and Obesity and Normal Weight that has completed, run by University of California, Los Angeles. The registered enrollment target is 32 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04686552, a NA study of Overweight and Obesity and Normal Weight, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The objective of the proposed study is to investigate the effect of cinnamon on the postprandial glycemic response to a high glycemic index meal in normal and overweight/obese prediabetic subjects

Interventions

  • DIETARY_SUPPLEMENT cinnamon

Study Locations (1)

California

  • UCLA Center for Human Nutrition - Los Angeles

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2018-01-01
Est. Completion 2020-01-01
Phase NA

What the Registry Record Tells You About NCT04686552

The ClinicalTrials.gov registry entry for NCT04686552 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (86% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 1 intervention - of which cinnamon is the first listed.

NCT04686552 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04686552 about?

NCT04686552 is a clinical study titled "Effect Cinnamon Spice on Postprandial Glucose and Insulin Responses". The objective of the proposed study is to investigate the effect of cinnamon on the postprandial glycemic response to a high glycemic index meal in normal and overweight/obese prediabetic subjects

What is the current status of trial NCT04686552?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-01-01. Estimated completion is 2020-01-01.

What conditions does trial NCT04686552 study?

This clinical trial studies the following conditions: Overweight and Obesity, Normal Weight.

What interventions are being tested in trial NCT04686552?

The interventions under investigation include: cinnamon (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04686552?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04686552 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.